Sign Up|Search Millions of Slides|Work With Us

Hello PitchDeckGuy readers!

Here are the top 5 decks we found on PitchSend today.

1. Novartis

Novartis continues to invest heavily in R&D at $3B in annual spend.

This slide deck highlights:

• $12.94B revenue with 6% YoY growth.

• $3.47B operating income.

• Core EPS $1.72, 12% rise.

• 19% of total sales invested into R&D.

• 50+ clinical trials ongoing.

2. Moderna

Moderna’s revenue hit $19.3B during the pandemic, more than 5x their average annual revenue.

This slide deck highlights:

• $5.9B in product sales.

• Personalized Cancer Vaccine in phase 1/2.

• $6.1B total revenue.

• mRNA-1647 CMV vaccine in development.

• $3.7B net income.

3. Teva Pharmaceuticals

Teva Pharmaceuticals supplies over 3,500 products in 60 countries.

This slide deck highlights:

• Top 5 global pharmaceutical company.

• Market leader in generic drugs.

• $16.4 billion in annual revenue.

• Global presence in over 60 countries.

• 32% rise in global net sales with AJOVY.

Reading this and not subscribed?

4. AstraZeneca

AstraZeneca continues to gain market dominance with $44B in annual revenue.

This slide deck highlights:

• Immuno-oncology revenue surpasses $5 billion.

• Core EPS up 17% to $5.80.

• Advanced 25 clinical trials to phase 3.

• 2.5B COVID vaccine doses.

• Market grew 14%, driven by China and Europe.

5. Sun Pharma

Sun Pharma expands globally with 70% of total revenue coming from outside the US.

This slide deck highlights:

• API business generates 6% of revenue.

• Market capitalization stands at $22B.

• Global market accounts for 15% of total revenue.

• Expanding consumer healthcare business.

• Sales per rep reaches 9.4M.

See you tomorrow,

-PitchDeckGuy

Reading this and not subscribed?